OrbiMed

United States

OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investmentsseries of venture capital funds and a family of public equity investment funds.

Founded:1989

Firm Location:United States • New Jersey • New York, New York • Chicago, Illinois • Philadelphia, Pennsylvania • San Francisco, California • Boston, Massachusetts • Boulder, Colorado • Hoboken, New Jersey • Hong Kong • London • San Francisco Bay Area • Israel

Investor Firms That Co-Invest with OrbiMed

InterWest Abingworth Biomatics Capital Partners Aisling Capital Meritech Capital Partners 1955 Capital DFJ Growth New Leaf Venture Partners RA Capital Management Something new Kain Capital Decheng Capital Deerfield Management De Novo Ventures Frazier Healthcare Partners Jmi Equity Tencent Holdings Pitango Venture Capital Atlas Venture Third Rock Ventures BDC Venture Capital Hatteras Venture Partners Samsara BioCapital Khosla Ventures Pear VC Westlake Village BioPartners Mott Family Capital Avoro Ventures Vivo Capital Sierra Ventures Great Oaks Venture Capital Sequoia Capital venBio Forbion Omega Funds Andera Partners Borealis Ventures Advent Life Sciences HealthQuest Capital Acorn Bioventures Action Potential Venture Capital Advanced Technology Ventures Emergence Capital U.S. Venture Partners (USVP)Red Tree Venture Capital Versant Ventures Menlo Ventures Canaan Partners 5am Ventures Presight Capital Dimension Capital GV (Google Ventures)B Capital Group Forge Life Science Partners OrbiMed Advisors Catalio Capital Management Sofinnova Partners General Catalyst Partners The Founders Fund Medical Excellence Capital, LLC Amplitude Ventures Kamanu Ventures & Lightspeed Venture Partners Scout Nextech Invest Ltd.Working on Something New F-Prime Capital (formerly Fidelity Biosciences)BrightEdge (American Cancer Society Impact Fund)Life Sciences Partners (LSP)GreenFig Formational Ventures

OrbiMed Team